These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19863833)

  • 1. The influence of breathing pattern during nebulization on the delivery of arformoterol using a breath simulator.
    Bauer A; McGlynn P; Bovet LL; Mims PL; Curry LA; Hanrahan JP
    Respir Care; 2009 Nov; 54(11):1488-92. PubMed ID: 19863833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Output and aerosol properties of 5 nebulizer/compressor systems with arformoterol inhalation solution.
    Bauer A; McGlynn P; Bovet LL; Mims PL; Curry LA; Hanrahan JP
    Respir Care; 2009 Oct; 54(10):1342-7. PubMed ID: 19796414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulized albuterol delivery in a model of spontaneously breathing children with tracheostomy.
    Berlinski A
    Respir Care; 2013 Dec; 58(12):2076-86. PubMed ID: 23674810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro estimations of in vivo jet nebulizer efficiency using actual and simulated tidal breathing patterns.
    Bosco AP; Rhem RG; Dolovich MB
    J Aerosol Med; 2005; 18(4):427-38. PubMed ID: 16379618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cumulative dose, safety and tolerability study of arformoterol in pediatric subjects with stable asthma.
    Hinkle J; Hinson J; Kerwin E; Goodwin E; Sciarappa K; Curry L; Hanrahan JP
    Pediatr Pulmonol; 2011 Aug; 46(8):761-9. PubMed ID: 21584948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of nebulizer type with different pediatric aerosol masks on drug deposition in a model of a spontaneously breathing small child.
    Lin HL; Wan GH; Chen YH; Fink JB; Liu WQ; Liu KY
    Respir Care; 2012 Nov; 57(11):1894-900. PubMed ID: 22418694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug output from nebulizers is dependent on the method of measurement.
    Barry PW; O'Callaghan C
    Eur Respir J; 1998 Aug; 12(2):463-6. PubMed ID: 9727802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nebulized arformoterol on airway function in COPD: results from two randomized trials.
    Hanrahan JP; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Baumgartner RA
    COPD; 2008 Feb; 5(1):25-34. PubMed ID: 18259972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of equipment dead space and pediatric breathing patterns on inhaled mass of nebulized budesonide.
    Nikander K; Denyer J; Smaldone GC
    J Aerosol Med; 1999; 12(2):67-73. PubMed ID: 10539709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breathing patterns and aerosol delivery: impact of regular human patterns, and sine and square waveforms on rate of delivery.
    Nikander K; Denyer J; Smith N; Wollmer P
    J Aerosol Med; 2001; 14(3):327-33. PubMed ID: 11693844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mask dead space and occlusion of mask holes on delivery of nebulized albuterol.
    Berlinski A
    Respir Care; 2014 Aug; 59(8):1228-32. PubMed ID: 24327744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD.
    Tashkin DP; Donohue JF; Mahler DA; Huang H; Goodwin E; Schaefer K; Hanrahan JP; Andrews WT
    Respir Med; 2009 Apr; 103(4):516-24. PubMed ID: 19208459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modified-blind, two-way crossover study.
    Panettieri RA; MacIntyre N; Sims M; Kerwin E; Fogarty C; Noonan M; Claus R; Andrews WT
    Clin Ther; 2009 Aug; 31(8):1716-23. PubMed ID: 19808130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
    Akapo S; Gupta J; Martinez E; McCrea C; Ye L; Roach M
    Ann Pharmacother; 2008 Oct; 42(10):1416-24. PubMed ID: 18780805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance.
    Donohue JF; Hanania NA; Sciarappa KA; Goodwin E; Grogan DR; Baumgartner RA; Hanrahan JP
    Ther Adv Respir Dis; 2008 Apr; 2(2):37-48. PubMed ID: 19124357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tiotropium and formoterol on quiet breathing pattern assessed by optoelectronic plethysmography in COPD patients: a pilot study.
    Dal Negro RW; Turati C; Micheletto C; Menegoni F
    Ther Adv Respir Dis; 2012 Apr; 6(2):97-105. PubMed ID: 22250038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel, versatile valved holding chamber for delivering inhaled medications to neonates and small children: laboratory simulation of delivery options.
    DiBlasi RM; Coppolo DP; Nagel MW; Doyle CC; Avvakoumova VI; Ali RS; Mitchell JP
    Respir Care; 2010 Apr; 55(4):419-26. PubMed ID: 20406509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of positive expiratory pressure devices attached to nebulizers.
    Berlinski A
    Respir Care; 2014 Feb; 59(2):216-22. PubMed ID: 23920213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of constant and breath-synchronized nebulization on inhaled mass of nebulized budesonide in infants and children.
    Nikander K; Bisgaard H
    Pediatr Pulmonol; 1999 Sep; 28(3):187-93. PubMed ID: 10495335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.